These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34290237)

  • 1. IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer.
    Tulotta C; Lefley DV; Moore CK; Amariutei AE; Spicer-Hadlington AR; Quayle LA; Hughes RO; Ahmed K; Cookson V; Evans CA; Vadakekolathu J; Heath P; Francis S; Pinteaux E; Pockley AG; Ottewell PD
    NPJ Breast Cancer; 2021 Jul; 7(1):95. PubMed ID: 34290237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1 drives breast cancer growth and bone metastasis in vivo.
    Holen I; Lefley DV; Francis SE; Rennicks S; Bradbury S; Coleman RE; Ottewell P
    Oncotarget; 2016 Nov; 7(46):75571-75584. PubMed ID: 27765923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of IL-1B in breast cancer bone metastasis.
    Zhou J; Ottewell PD
    J Bone Oncol; 2024 Jun; 46():100608. PubMed ID: 38800348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of IL-1B in breast cancer bone metastasis.
    Tulotta C; Ottewell P
    Endocr Relat Cancer; 2018 Jul; 25(7):R421-R434. PubMed ID: 29760166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone Metastasis.
    Zhou J; Down JM; George CN; Murphy J; Lefley DV; Tulotta C; Alsharif MA; Leach M; Ottewell PD
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
    Lefley D; Howard F; Arshad F; Bradbury S; Brown H; Tulotta C; Eyre R; Alférez D; Wilkinson JM; Holen I; Clarke RB; Ottewell P
    Breast Cancer Res; 2019 Nov; 21(1):130. PubMed ID: 31783893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1β in breast cancer bone metastasis.
    Zhou J; Tulotta C; Ottewell PD
    Expert Rev Mol Med; 2022 Mar; 24():e11. PubMed ID: 35227338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment.
    Tulotta C; Lefley DV; Freeman K; Gregory WM; Hanby AM; Heath PR; Nutter F; Wilkinson JM; Spicer-Hadlington AR; Liu X; Bradbury SMJ; Hambley L; Cookson V; Allocca G; Kruithof de Julio M; Coleman RE; Brown JE; Holen I; Ottewell PD
    Clin Cancer Res; 2019 May; 25(9):2769-2782. PubMed ID: 30670488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAT1 promotes osteolytic metastasis in luminal breast cancer by regulating the bone metastatic niche via NF-κB/IL-1B signaling pathway.
    Zhao C; Cai X; Wang Y; Wang D; Wang T; Gong H; Sun H; Jia Q; Zhou W; Wu Z; Li Z; Xiao J
    Am J Cancer Res; 2020; 10(8):2464-2479. PubMed ID: 32905535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells.
    Nakata A; Tsujimura T; Sugihara A; Okamura H; Iwasaki T; Shinkai K; Iwata N; Kakishita E; Akedo H; Terada N
    Anticancer Res; 1999; 19(5B):4131-8. PubMed ID: 10628364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
    Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
    J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 11 (IL-11): Role(s) in Breast Cancer Bone Metastases.
    Maroni P; Bendinelli P; Ferraretto A; Lombardi G
    Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34201209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine.
    Hart NH; Galvão DA; Saunders C; Taaffe DR; Feeney KT; Spry NA; Tsoi D; Martin H; Chee R; Clay T; Redfern AD; Newton RU
    Trials; 2018 Dec; 19(1):695. PubMed ID: 30572928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The curability of breast cancer and the treatment of advanced disease.
    Guarneri V; Conte PF
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions.
    George CN; Canuas-Landero V; Theodoulou E; Muthana M; Wilson C; Ottewell P
    J Bone Oncol; 2020 Dec; 25():100317. PubMed ID: 32995253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.
    Cai WL; Huang WD; Li B; Chen TR; Li ZX; Zhao CL; Li HY; Wu YM; Yan WJ; Xiao JR
    Mol Cancer; 2018 Jan; 17(1):9. PubMed ID: 29343249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization.
    Castaño Z; San Juan BP; Spiegel A; Pant A; DeCristo MJ; Laszewski T; Ubellacker JM; Janssen SR; Dongre A; Reinhardt F; Henderson A; Del Rio AG; Gifford AM; Herbert ZT; Hutchinson JN; Weinberg RA; Chaffer CL; McAllister SS
    Nat Cell Biol; 2018 Sep; 20(9):1084-1097. PubMed ID: 30154549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue.
    Bohlen J; McLaughlin SL; Hazard-Jenkins H; Infante AM; Montgomery C; Davis M; Pistilli EE
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):701-714. PubMed ID: 29582584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans.
    Kamalakar A; Bendre MS; Washam CL; Fowler TW; Carver A; Dilley JD; Bracey JW; Akel NS; Margulies AG; Skinner RA; Swain FL; Hogue WR; Montgomery CO; Lahiji P; Maher JJ; Leitzel KE; Ali SM; Lipton A; Nicholas RW; Gaddy D; Suva LJ
    Bone; 2014 Apr; 61():176-85. PubMed ID: 24486955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
    David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
    PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.